SLEEP CBD GUMMIES WITH MELATONIN
DELICIOUS CBD GUMMIES FOR SLEEP AND RELAXATION*
Get a good night’s sleep and experience the natural benefits of pure CBD with our SLEEP CBD with Melatonin Gummies.
SLEEP CBD Gummies features:
- Perfect Natural Sleep Aid;*
- Helps support a good night’s sleep;*
- Helps prevent sleeplessness;*
- Improves sleep quality;*
- Supports a calm peaceful state to allow relaxation and sleep;*
- Potent 25mg CBD isolate per gummy;
- 5mg Melatonin per gummy;
- Delicious natural fruit flavors;
- Packed with our CBD therapeutic formula;
- Laboratory tested for safety, purity, and potency;
- Free from pesticides, solvents, and chemical fertilizers.
Better Sleep for Better Health!
Check out some of our customer reviews…
FREQUENTLY ASKED QUESTIONS (FAQs)
We have compiled a list of the most frequently asked questions here, with answers by our panel of experts.
SLEEP CBD Gummies are the most delicious way to consume all-natural CBD in a convenient gummy snack. Science-based formulated and infused with 25 mg of pure CBD isolate and 5mg Melatonin per gummy, SLEEP CBD Gummies can make any situation more relaxing. SLEEP CBD Gummies offer a unique experience for CBD consumers that sets them apart from tinctures, topicals, and other forms of CBD. Because gummies are consumed orally, they – like other CBD edibles – typically produce longer-lasting effects than other forms of CBD oil, such as tinctures or vape oils. SLEEP CBD gummies provide a fun and effective way to consume this beneficial cannabinoid.
- People with sleeping problems who want to fight them and feel more relaxed when they wake up;
- People who are struggling to get to sleep, wake up often in the night, suffer from insomnia, or don’t feel refreshed when they wake up;
- People who want to optimise their sleep;
- People who don’t feel completely relaxed when they wake up and finally want to improve their sleep;
- People who work afternoon to nighttime or nighttime to early morning hours and are affected by shift work disorder;
- People traveling across different time zones.
For trouble falling asleep:
Take 1 gummy 30 minutes before bedtime.
Chew thoroughly before swallowing.
For night owls:
People with delayed sleep phase syndrome can take 1 gummy several hours before the desired bedtime.
Chew thoroughly before swallowing.
For early birds:
If you have symptoms of advanced sleep phase syndrome, where you wake up several hours too early, take 1 gummy in the morning upon awakening. This condition is relatively rare, however, perhaps affecting less than 1 percent of people. If considering use in this way, consult with a sleep physician for guidance. Chew thoroughly before swallowing.
For some people, results are immediate. Since everyone has different needs and preferences, the right CBD dose will vary per individual user. In order to determine the best CBD dosage for you, it is recommended you start with small daily doses and build your way up gradually until you achieve the desired results. It may take up to two hours if taken via an edible. A lot of people give up too soon, or don’t do enough experimenting to figure out what dose is appropriate.
- Serving Size1 CBD Gummy
- Servings Per Container30
- Calories from Fat0
- Food ComponentAmount/Serving% Daily Value*
- CBD25 mg
- Melatonin5 mg
Other Ingredients: Other Ingredients: Corn Syrup (From Corn), Sugar (From Beets), Water, Gelatin, Citric Acid, Natural and Artificial Flavors, Pectin (Derived from Fruits), Vegetable Oil (Coconut, Canola) and Carnauba Leaf Wax (To Prevent Sticking), FD&C Yellow #5, FD&C Red #40, FD&C Yellow #6, FD&C Blue #1.
- All Natural
- Suitable for Vegans: No
- Suitable for Vegetarians: No
- Third Party Tested: Yes
- 30 CBD Gummies: 1 Month Supply
- Non-GMO / Dairy Free / Gluten Free : Yes/Yes/Yes
- U.S.A manufactured in a GMP facility
- Yuuto™ Nutrition proudly uses only the highest quality ingredients
CBD is NOT Psychoactive like other drugs because it has Non-Detectable THC.
CAUTION: Keep at room temperature to preserve freshness. Store away from humidity, heat, and light. If any adverse reactions occur, discontinue use of dietary supplement and consult your doctor.
CONSULT YOUR HEALTHCARE PROVIDER BEFORE TAKING THIS SUPPLEMENT IF YOU ARE PREGNANT OR NURSING, OR HAVE ANY OTHER MEDICAL CONCERNS.
The Supplement Facts labeling information contained within this website should be regarded as the most up to date and may differ from product labeling that you have purchased. Please consult your product package for information, including allergens, specific to the product you have purchased.
Cannabidiol, or CBD, is a cannabinoid, or naturally occurring biochemical found in cannabis plants. Cannabinoids interact with the endocannabinoid system in humans, and these reactions can affect sleep, mood, pain, and appetite. CBD does not produce any psychoactive effects on its own and will not make people feel high, as is the case with other cannabinoids like tetrahydrocannabinol (THC). As a result, CBD products are widely used to alleviate symptoms for a wide range of medical conditions and disorders.
CBD is known for providing a number of positive benefits:
- Reduced inflammation, improving pain and swelling for people with problems like arthritis;*
- Increased relaxation and ability to fall asleep;*
- Reduced anxiety and depression;*
- Improved sociability;*
- Improved concentration;*
- Improved digestion.*
According to the World Health Organization, CBD “is generally well tolerated, with a good safety profile.” You should speak to your doctor about how CBD may interact with any medications you’re currently taking.
Melatonin is extremely safe. It is a hormone that your body makes naturally. It is not habit-forming, and you will not become addicted or dependent upon it. It can be used on a nightly basis without fear of adverse consequences.
It is legal to sell and purchase CBD as long as the THC percentage is less than .3%, and you’re at the age of 18 or older.
The information presented here is intended for informational purposes only, and is meant to help users better understand health concerns. Information is based on review of scientific research data, historical practice patterns, and clinical experience.
Food supplements must not be used as a substitute for a varied, nutritional and balanced diet. If you are pregnant, breastfeeding, taking any medication or are currently undergoing medical advice, please consult a doctor or healthcare professional before use.
Refrain from taking the food supplements if adverse reactions occur and consult a doctor.
Keep out of reach of young children.
Do not use if the goods are received without a tamper strip securely in place.
All Yuuto Nutrition products come with 30-day risk-free money back guarantee. If you do not see results after taking the product for 30 days, you can return your empty bottle for a full product refund. For full details on our guarantee, visit our Shipping and Returns page.
 K. Doheny, “As CBD Oil Flirts with Mainstream, Questions Mount,” WebMD, 05 June 2018. [Online]. Available: https://www.webmd.com/pain-management/news/20180605/as-cbd-oil-flirts-with-mainstream-questions-mount.
 E. M. Blessing, M. M. Steenkamp, J. Manzanares and C. R. Marmar, “Cannabidiol as a Potential Treatment for Anxiety Disorders,” Download PDF, vol. 12, no. 4, p. 825–836, 2015.
 J. L. C. Lee, L. J. Bertoglio, F. S. Guimarães and C. W. Stevenson, “Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders,” British Journal of Pharmacology, vol. 174, no. 19, 2017.
 Y. L. Hurd, “Cannabidiol: Swinging the Marijuana Pendulum From ‘Weed’ to Medication to Treat the Opioid Epidemic,” Trends in Neurosciences, vol. 40, no. 3, pp. 124-127, 2017.
 F. Grotenhermen, E. Russo and A. W. Zuardi, “Even High Doses of Oral Cannabidiol Do Not Cause THC-Like Effects in Humans,” Cannabis and Cannabinoid Research, vol. 2, no. 1, 2017.
 A. Cadena, “What’s the Best CBD Dosage?,” Medium, 25 February 2018. [Online]. Available: https://medium.com/cbd-origin/whats-the-best-cbd-dosage-81ec4f95503b.
 n.a., “Depression and Other Common Mental Disorders: Global Health Estimates,” World Health Organization, Geneva, 2017.
 R. E. Musty, “Cannabinoids and anxiety,” in Cannabinoids as Therapeutics, Basel, Birkhäuser, 2005, pp. 141-147.
 D. R. Wilson, “Using CBD Oil for Anxiety: Does It Work?,” Healthline Media, 10 April 2017. [Online]. Available: https://www.healthline.com/health/cbd-for-anxiety.
 J. A. S. Crippa, G. N. Deremusson, T. B. Ferrari and a. others, “Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report,” Journal of Psychopharmacology, vol. 25, no. 1, 2010.
 M. M. Bergamaschi, R. H. Costa Queiroz, M. H. Nisihara Chagas and a. others, “Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients,” Neuropsychopharmacology , vol. 36, p. 1219–1226, 2011.
 n.a., “CANNABIDIOL (CBD) Critical Review Report,” World Health Organization, Geneva, 2018.
 F. Borrelli, G. Aviello, B. Romano, P. Orlando, R. Capasso, F. Maiello and a. others, “Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis,” Journal of Molecular Medicine, vol. 87, p. 1111, 2009.
 G. Aviello, B. Romano, F. Borrelli, R. Capasso, L. Gallo, F. Piscitelli, V. Di Marzo and A. A. Izzo, “Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer,” Journal of Molecular Medicine, vol. 90, no. 8, p. 925–934, 2012.
 C. Wong, “Can CBD Oil Treat Anxiety?,” Verywell, 23 October 2018. [Online]. Available: https://www.verywellhealth.com/cbd-oil-for-anxiety-4176279.
 S. Shannon and J. Opila-Lehman, “Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report,” The Permanente Journal, vol. 20, no. 4, pp. 108-111, 2016.
 A. Campos, Z. Ortega, J. Palazuelos, M. Fogaca, D. Aguiar, J. Diaz-Alonso, S. Ortega-Gutierrez and a. others, “The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system.,” International Journal of Neuropsychopharmacology, vol. 16, no. 6, pp. 1407-1419, 2013.
 R. Mechoulam, M. Peters, Murillo-Rodriguez, Eric and L. O. Hanuš, “Cannabidiol – Recent Advances,” Chemistry & Biodiversity, vol. 4, no. 8, pp. 1678-1692, 2007.
 “Chemistry and Analysis of Phytocannabinoids and Other Cannabis Constituents,” Medical Genomics, Rudolf Brenneisen, https://www.medicinalgenomics.com/wp-content/uploads/2011/12/Chemical-constituents-of-cannabis.pdf.
 “Hashish. I. The structure of cannabidiol,” Tetrahedron 19: 2073–2078, R. Mechoulam and Y. Shvo. (1963) https://www.ncbi.nlm.nih.gov/pubmed/5879214.
 “The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain,” European Neuropsychopharmacology, A.-L. Klauke et al. Volume 24, Issue 4, 608–620
 EPIDIOLEX (cannabidiol) oral solution—FDA approved epilepsy treatment drug, package insert and prescribing information https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210365lbl.pdf.
 “Cannabidiol: State of the art and new challenges for therapeutic applications,” Pharmacology & Therapeutics, S. Pisanti et al. 175: 133–150. https://www.ncbi.nlm.nih.gov/pubmed/28232276.
 Greenwich Biosciences Announces FDA Approval of EPIDIOLEX® (cannabidiol) Oral Solution—the First Plant-derived Cannabinoid Prescription Medicine, Press Release, June 25, 2018. https://www.greenwichbiosciences.com/about-us/news/greenwich-biosciences-announces-fda-approval-epidiolex%C2%AE-cannabidiol-oral-solution-%E2%80%93.
 Barion A, Zee PC. A clinical approach to circadian rhythm sleep disorders. Sleep Medicine. 2007;8(6):566–577.
 Ferguson SA, Rajaratnam SM, Dawson D. Melatonin agonists and insomnia. Expert Review of Neurotherapeutics. 2010;10(2):305–318.
 Gooneratne NS. Complementary and alternative medicine for sleep disturbances in older adults. Clinics in Geriatric Medicine. 2008;24(1):121–138.
 Herxheimer A, Petrie KJ. Melatonin for the prevention and treatment of jet lag. Cochrane Database of Systematic Reviews. 2002;(2):CD001520 [edited 2009]. Accessed at www.thecochranelibrary.com on April 10, 2014.
 Jansen SL, Forbes D, Duncan V, et al. Melatonin for the treatment of dementia. Cochrane Database of Systematic Reviews. 2006;(1):CD003802 [edited 2011]. Accessed at www.thecochranelibrary.com on April 10, 2014.
 Morgenthaler T, Lee-Chiong T, Alessi C, et al. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders: an American Academy of Sleep Medicine report. Sleep. 2007;30(11):1445–1459.
 van Geijlswijk IM, Korzilius HP, Smits MG. The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis. Sleep. 2010;33(12):1605–1614.
 Arendt JA, Rajaratnam SM. Melatonin and its agonists: an update. British Journal of Psychiatry. 2008;193(4):267–269.
 Arendt J. Shift work: coping with the biological clock. Occupational Medicine. 2010;60(1):10–20.
 Bellapart J, Boots R. Potential use of melatonin in sleep and delirium in the critically ill. British Journal of Anaesthesia. 2012;108(4):572–580.
 Cardinali DP, Furio AM, Brusco LI. Clinical aspects of melatonin intervention in Alzheimer’s disease progression. Current Neuropharmacology. 2010;8(3):218–227.
 Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One. 2013;8(5):e63773.
 Grossman E, Laudon M, Zisapel N. Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials. Vascular Health and Risk Management.2011;7:577–584.
 Herxheimer A. Jet lag. Clinical Evidence. 2008;12:2303.
 Lemoine P, Nir T, Laudon M, et al. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects. Journal of Sleep Research. 2007;16(4):372–380.
 Lemoine P, Zisapel N. Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia. Expert Opinion on Pharmacotherapy. 2012;13(6):895–905.
 Morin AK. Strategies for treating chronic insomnia. American Journal of Managed Care. 2006;12(8 Suppl):S230–S245.
 Reiter RJ, Tan D-X, Manchester LC, et al. Medical implications of melatonin: receptor-mediated and receptor-independent actions. Advances in Medical Sciences. 2007;52:11–28.
 Riemersma-van der Lek RF, Swaab DF, Twisk J, et al. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. JAMA. 2008;299(22):2642–2655.
 Rosenberg R, Doghramji PP. Is shift work making your patient sick? Emerging theories and therapies for treating shift work disorder. Postgraduate Medicine. 2011;123(5):106–115.
 Wang X. The anti-apoptotic activity of melatonin in neurodegenerative diseases. CNS Neuroscience & Therapeutics. 2009;15(4):345–357.
 Zee PC, Goldstein CA. Treatment of shift work disorder and jet lag. Current Treatment Options in Neurology. 2010;12(5):396–411.
 Melatonin: In depth. National Center for Complementary and Integrative Health. https://nccih.nih.gov/health/melatonin. Accessed Sept. 12, 2017.
 Melatonin. Natural Medicines. https://naturalmedicines.therapeuticresearch.com. Accessed Sept. 12, 2017.
 Ferracioli-Oda E, et al. Meta-analysis: Melatonin for the treatment of primary sleep disorders. PLOS One. 2014;8:e63773.
 Auld F, et al. Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep Medicine Reviews. 2017;34:10.
 Auger RR, et al. Clinical practice guideline for the treatment of intrinsic circadian rhythm sleep-wake disorders: Advanced sleep-wake phase disorder (ASWPD), delayed sleep-wake phase disorder (DSWPD), non-24-hour sleep-wake rhythm disorder (N24SWD), and irregular sleep-wake rhythm disorder (ISWRD). An Update for 2015: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2015;11:1199.
 Melatonin. Facts & Comparisons eAnswers. http://www.wolterskluwercdi.com/facts-comparisons-online/. Accessed Sept. 14, 2017